AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges-Reference-Cited by-同舟云学术

AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges

Published:2015-02-18 Issue:7541 Volume:519 Page:87-91
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Gardner Matthew R.,Kattenhorn Lisa M.,Kondur Hema R.,von Schaewen Markus,Dorfman Tatyana,Chiang Jessica J.,Haworth Kevin G.,Decker Julie M.,Alpert Michael D.,Bailey Charles C.,Neale Ernest S.,Fellinger Christoph H.,Joshi Vinita R.,Fuchs Sebastian P.,Martinez-Navio Jose M.,Quinlan Brian D.,Yao Annie Y.,Mouquet Hugo,Gorman Jason,Zhang Baoshan,Poignard Pascal,Nussenzweig Michel C.,Burton Dennis R.,Kwong Peter D.,Piatak Michael,Lifson Jeffrey D.,Gao Guangping,Desrosiers Ronald C.,Evans David T.,Hahn Beatrice H.,Ploss Alexander,Cannon Paula M.,Seaman Michael S.,Farzan Michael

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature14264.pdf

Reference50 articles.

1. Balazs, A. B. et al. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature 481, 81–84 (2011)

2. Johnson, P. R. et al. Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys. Nature Med. 15, 901–906 (2009)

3. Diskin, R. et al. Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science 334, 1289–1293 (2011)

4. Huang, J. et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 491, 406–412 (2012)

5. Walker, L. M. et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466–470 (2011)

Cited by 263 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current developments of gene therapy in human diseases;MedComm;2024-08-16

2. Biotech's role in advancing HIV vaccine development;Emerging Microbes & Infections;2024-08-12

3. Modelling HIV-1 control and remission;npj Systems Biology and Applications;2024-08-08

4. HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapy;2024-07-12

5. Adeno-associated viral delivery of Env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapy;2024-06-03